PMC:7600245 / 41397-41654
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T153 | 15-50 | Disease | denotes | acute respiratory distress syndrome | http://purl.obolibrary.org/obo/MONDO_0006502 |
| T154 | 21-50 | Disease | denotes | respiratory distress syndrome | http://purl.obolibrary.org/obo/MONDO_0009971 |
| T155 | 155-163 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T379 | 52-55 | http://purl.obolibrary.org/obo/CLO_0054061 | denotes | 132 |
| T380 | 197-205 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T26 | 21-41 | Phenotype | denotes | respiratory distress | http://purl.obolibrary.org/obo/HP_0002098 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T311 | 58-173 | Sentence | denotes | Currently, selinexor is being evaluated in at least two phase 2 randomized trials in the U.S. in COVID-19 patients. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1239 | 15-50 | Disease | denotes | acute respiratory distress syndrome | MESH:D012128 |
| 1250 | 164-172 | Species | denotes | patients | Tax:9606 |
| 1255 | 155-163 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 1256 | 231-240 | Disease | denotes | mortality | MESH:D003643 |